Recall: D-0771-2026

Class II - Potentially Harmful

Class IIClassification

2026-08-07Initiated

OngoingStatus

Golden State Medical Supply InFirm

Product

Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA

Reason

CGMP deviations: tablets with black specks.

Distribution

USA Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.